Abstract

Transfusions after surgery are increasingly recognized as a risk factor for major adverse outcomes, such as infection, immuno-compromise, increased hospital length-of-stay and even mortality. In patients with peripheral artery disease, the balance between mitigating bleeding risk and providing effective thromboprophylaxis is complex given the variation in individual response to antithrombotic therapy. Currently, prevention of transfusions are limited by a lack of routine coagulation profiling that is comprehensive, accounts for the effects of all medication types including the commonly used class of direct oral anticoagulants, and measures varied subject-specific responsiveness.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.